Alexion Pharmaceuticals
Headquartered in Cheshire, Connecticut (USA), Alexion is global biopharmaceutical company focused on the development and delivery of life-transforming therapies for patients with severe and life-threatening rare disorders.
Financial Data
-
31st Dec 18 Source: Estimated
- €514.4 million turnover
- 400 employees
-
31st Dec 17 Source: Estimated
- €321.6 million turnover
- 300 employees
- 4 more years available »
Ranking
By Turnover
(€514.4 million)- 154th in Top Companies
- 22nd in Health
- 20th in Pharma
By Employees
(400)- 414th in Top Companies
- 65th in Health
- 42nd in Pharma
- 400
- €514.4 million
Employees
- Shane Doyle Senior vice president
Latest News
- 6:30am Quinn Insurance and PwC’s audit, An Post’s gender pay gap, and theatre profits
- 5:45am Bord Gáis theatre records strong growth in turnover and profits
- 5:25am Iconic Newspapers in talks to acquire Munster Express
- 5:20am Former Elan executive Given joins Philip Lee’s corporate deals team
- 5:20am Study finds investors will give up gains for sustainable options